B Balint

Summary

Publications

  1. pmc Gene Mutation Profiles in Primary Diffuse Large B Cell Lymphoma of Central Nervous System: Next Generation Sequencing Analyses
    Milena Todorovic Balint
    Clinic for Hematology, Clinical Center of Serbia, Belgrade 11000, Serbia
    Int J Mol Sci 17:. 2016
  2. pmc Multiple malignancies in a female patient with common variable immunodeficiency syndrome
    Milena Todorovic
    Clinic for Hematology, Clinical Center of Serbia, 11000 Belgrade, Serbia
    Singapore Med J 55:e162-4. 2014
  3. doi request reprint Increased angiogenesis-associated poor outcome in acute lymphoblastic leukemia: a single center study
    Milena Todorovic
    Clinic for Hematology, Clinical Center of Serbia, Belgrade, Serbia
    Appl Immunohistochem Mol Morphol 20:488-93. 2012
  4. doi request reprint Outcome prediction of advanced mantle cell lymphoma by international prognostic index versus different mantle cell lymphoma indexes: one institution study
    Milena Todorovic
    Clinic of Hematology, Clinical Center of Serbia, 11000 Belgrade, Serbia
    Med Oncol 29:2212-9. 2012
  5. ncbi request reprint Immunophenotypic profile and clinical characteristics in patients with advanced stage mantle cell lymphoma
    M Todorovic
    Institute of Hematology, Clinical Center of Serbia, Belgrade, Serbia
    Med Oncol 24:413-8. 2007
  6. pmc Primary gastric mucosa associated lymphoid tissue lymphoma: clinical data predicted treatment outcome
    Milena Todorovic
    Institute of Hematology, Clinical Center of Serbia, Belgrade, Serbia
    World J Gastroenterol 14:2388-93. 2008
  7. doi request reprint Triple-way therapeutic approach for paraganglioma-dependent erythrocytosis: drugs and surgery plus "multi-manner" apheresis
    M Todorovic
    Institute of Hematology, Clinical Center of Serbia, Belgrade, Serbia
    Med Oncol 25:148-53. 2008

Collaborators

  • Darko Antic
  • Vladimir Jurisic
  • Biljana Mihaljevic
  • Milena Todorovic
  • Bosko Andjelic
  • M Todorovic
  • Milena Todorovic Balint
  • Ziv Radisavljevic
  • M Colovic
  • M Pavlovic
  • I Elezovic
  • Jelena Bila
  • Bojana Stanic
  • Nadja Pejanovic
  • Natasa Tosic
  • Sava Raicevic
  • Miloš Popović
  • Teodora Karan-Djurasevic
  • Bojana Lucic
  • Jelena Kostic
  • Jelena Jelicic
  • Sonja Pavlovic
  • Maja Stojiljkovic
  • Irena Marjanovic
  • Ognjen Perisic
  • Goran Rakocevic
  • Dejana Stanisavljevic
  • Nada Kraguljac Kurtovic
  • Vera Todorovic
  • Maja Perunicic Jovanovic
  • V Popovic
  • Dragana Stamatovic
  • Maja Perunicic
  • Olivera Markovic
  • M Petrovic
  • R Milenkovic
  • Slobodan Marjanovic
  • M Jevtic
  • Nada Suvajdzic
  • N Suvajdzic
  • M Krstic
  • Amela Ceric
  • Miodrag Krstic
  • Miodrag Jevtic
  • B Ivanovic
  • D Boskovic
  • N Kraguljac
  • A Bogdanovic

Detail Information

Publications7

  1. pmc Gene Mutation Profiles in Primary Diffuse Large B Cell Lymphoma of Central Nervous System: Next Generation Sequencing Analyses
    Milena Todorovic Balint
    Clinic for Hematology, Clinical Center of Serbia, Belgrade 11000, Serbia
    Int J Mol Sci 17:. 2016
    ..Our findings suggest that the TP53 and ATM genes could be involved in the molecular pathophysiology of primary DLBCL CNS, whereas mutations in the PTEN and SMO genes could affect survival regardless of the initial treatment approach. ..
  2. pmc Multiple malignancies in a female patient with common variable immunodeficiency syndrome
    Milena Todorovic
    Clinic for Hematology, Clinical Center of Serbia, 11000 Belgrade, Serbia
    Singapore Med J 55:e162-4. 2014
    ..To the best of our knowledge, this is the first reported case of CVID associated with multiple solid tumours and DLBCL...
  3. doi request reprint Increased angiogenesis-associated poor outcome in acute lymphoblastic leukemia: a single center study
    Milena Todorovic
    Clinic for Hematology, Clinical Center of Serbia, Belgrade, Serbia
    Appl Immunohistochem Mol Morphol 20:488-93. 2012
    ..Thus, targeting VEGF pathway may bring the new approach for ALL treatment-using antiangiogenic drugs and tyrosine kinase inhibitors in combination with standard chemotherapy regimens...
  4. doi request reprint Outcome prediction of advanced mantle cell lymphoma by international prognostic index versus different mantle cell lymphoma indexes: one institution study
    Milena Todorovic
    Clinic of Hematology, Clinical Center of Serbia, 11000 Belgrade, Serbia
    Med Oncol 29:2212-9. 2012
    ..01) for OS in uniformly treated advanced MCL patients, although sMIPI prognostic significance was the highest (P < 0.001)...
  5. ncbi request reprint Immunophenotypic profile and clinical characteristics in patients with advanced stage mantle cell lymphoma
    M Todorovic
    Institute of Hematology, Clinical Center of Serbia, Belgrade, Serbia
    Med Oncol 24:413-8. 2007
    ..001). Our results demonstrated that in the advanced MCL patients the most powerful prognostic factor was IPI, while extranodal localization and type of BM infiltration were of a limited value...
  6. pmc Primary gastric mucosa associated lymphoid tissue lymphoma: clinical data predicted treatment outcome
    Milena Todorovic
    Institute of Hematology, Clinical Center of Serbia, Belgrade, Serbia
    World J Gastroenterol 14:2388-93. 2008
    ..To determine clinical characteristics and treatment outcome of gastric lymphoma after chemotherapy and immuno-chemotherapy...
  7. doi request reprint Triple-way therapeutic approach for paraganglioma-dependent erythrocytosis: drugs and surgery plus "multi-manner" apheresis
    M Todorovic
    Institute of Hematology, Clinical Center of Serbia, Belgrade, Serbia
    Med Oncol 25:148-53. 2008
    ....